Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury

被引:33
作者
Filippidis, Aristotelis S. [1 ]
Papadopoulos, Dimitrios C. [2 ]
Kapsalaki, Eftychia Z. [3 ]
Fountas, Kostas N. [1 ]
机构
[1] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Neurosurg, Biopolis, Larissa, Greece
[2] Gen Hosp Larissa, Dept Crit Care Med, Larisa, Greece
[3] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Diagnost Radiol, Biopolis, Larissa, Greece
关键词
biomarker; children; mild traumatic brain injury; S100B biomarker; NEURON-SPECIFIC ENOLASE; PROTEIN; HEAD; EMPHASIS; RELEASE; MARKERS; DAMAGE;
D O I
10.3171/2010.8.FOCUS10185
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The aim of this study was to provide a systematic update of the current literature regarding the clinical role of the S100B serum biomarker in the initial evaluation of children who have sustained a mild traumatic brain injury (TBI). Methods. Searches in MEDLINE were defined with the keywords "mild TBI children S100," "mild TBI pediatric S100," and " children S100 brain injury." From the pool of obtained studies, those that had the inclusion criteria of mild TBI only or mixed types of TBI but including detailed information about groups of children with mild TBI were used. Results. Few studies were identified and fewer included more than 100 cases. The prospective studies showed that the S100B biomarker levels could be influenced by patient age and the time frame between head injury and blood sampling. Moreover, extracranial sources of S100B or additional injuries could influence the measured levels of this biomarker. A normal value of S100B in children with mild TBI could rule out injury-associated abnormalities on CT scans in the majority of reported cases. Conclusions. The vulnerability of S100B serum levels to the influences of patient age, blood sampling time, and extracranial S100B release limits the biomarker's role in the initial evaluation of children with mild TBI. The application of S100B in pediatric mild TBI cases has an elusive role, although it could help in selected cases to avoid unnecessary head CT scans. (DOI: 10.3171/2010.8.FOCUS10185)
引用
收藏
页码:1 / 5
页数:5
相关论文
共 27 条
[1]  
Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322
[2]   High serum S100B levels for trauma patients without head injuries [J].
Anderson, RE ;
Hansson, LO ;
Nilsson, O ;
Dijlai-Merzoug, R ;
Settergren, G .
NEUROSURGERY, 2001, 48 (06) :1255-1258
[3]   Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children [J].
Berger, RP ;
Adelson, PD ;
Pierce, MC ;
Dulani, T ;
Cassidy, LD ;
Kochanek, PM .
JOURNAL OF NEUROSURGERY, 2005, 103 (01) :61-68
[4]   Neuroprotein s-100B-a useful parameter in paediatric patients with mild traumatic brain injury? [J].
Castellani, C. ;
Bimbashi, P. ;
Ruttenstock, E. ;
Sacherer, P. ;
Stojakovic, T. ;
Weinberg, A-M .
ACTA PAEDIATRICA, 2009, 98 (10) :1607-1612
[5]   Reference ranges for neuroprotein S-100B: from infants to adolescents [J].
Castellani, Christoph ;
Stojakovic, Tatjana ;
Cichocki, Martin ;
Scharnagl, Hubert ;
Erwa, Wolfgang ;
Gutmann, Anton ;
Weinberg, Annelie-Martina .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (09) :1296-1299
[6]   Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury [J].
Dash, Pramod K. ;
Zhao, Jing ;
Hergenroeder, Georgene ;
Moore, Anthony N. .
NEUROTHERAPEUTICS, 2010, 7 (01) :100-114
[7]   Pediatric concentrations of S100B protein in blood: Age- and sex-related changes [J].
Gazzolo, D ;
Michetti, F ;
Bruschettini, M ;
Marchese, N ;
Lituania, M ;
Mangraviti, S ;
Pedrazzi, E ;
Bruschettini, P .
CLINICAL CHEMISTRY, 2003, 49 (06) :967-970
[8]   Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury Clinical article [J].
Geyer, Chrisrian ;
Ulrich, Anett ;
Graefe, Gerd ;
Stach, Barbara ;
Till, Holger .
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2009, 4 (04) :339-344
[9]   S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma [J].
Hatpio, R ;
Einarsson, R .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :512-518
[10]  
Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171